Special Article
IgG4-related disease: Is rituximab the best therapeutic strategy for cases refractory to conventional therapy? Results of a systematic review
Enfermedad relacionada con IgG4: ¿es el rituximab la mejor estrategia terapéutica en los casos refractarios a terapia convencional? Resultados de una revisión sistemática
Read
10424
Timeswas read the article
3123
Total PDF
7301
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 0 | 97 | 97 |
| 2025 9 | 0 | 143 | 143 |
| 2025 8 | 0 | 108 | 108 |
| 2025 7 | 0 | 64 | 64 |
| 2025 6 | 5 | 36 | 41 |
| 2025 5 | 207 | 72 | 279 |
| 2025 4 | 203 | 50 | 253 |
| 2025 3 | 188 | 50 | 238 |
| 2025 2 | 178 | 45 | 223 |
| 2025 1 | 281 | 74 | 355 |
| 2024 12 | 218 | 57 | 275 |
| 2024 11 | 117 | 101 | 218 |
| 2024 10 | 98 | 37 | 135 |
| 2024 9 | 164 | 22 | 186 |
| 2024 8 | 170 | 55 | 225 |
| 2024 7 | 175 | 45 | 220 |
| 2024 6 | 128 | 43 | 171 |
| 2024 5 | 214 | 46 | 260 |
| 2024 4 | 132 | 50 | 182 |
| 2024 3 | 174 | 45 | 219 |
| 2024 2 | 186 | 51 | 237 |
| 2024 1 | 143 | 24 | 167 |
| 2023 12 | 147 | 38 | 185 |
| 2023 11 | 164 | 38 | 202 |
| 2023 10 | 188 | 47 | 235 |
| 2023 9 | 197 | 46 | 243 |
| 2023 8 | 287 | 19 | 306 |
| 2023 7 | 111 | 34 | 145 |
| 2023 6 | 74 | 25 | 99 |
| 2023 5 | 84 | 38 | 122 |
| 2023 4 | 81 | 22 | 103 |
| 2023 3 | 133 | 48 | 181 |
| 2023 2 | 110 | 35 | 145 |
| 2023 1 | 100 | 32 | 132 |
| 2022 12 | 135 | 43 | 178 |
| 2022 11 | 101 | 47 | 148 |
| 2022 10 | 133 | 49 | 182 |
| 2022 9 | 98 | 48 | 146 |
| 2022 8 | 81 | 43 | 124 |
| 2022 7 | 101 | 58 | 159 |
| 2022 6 | 83 | 56 | 139 |
| 2022 5 | 105 | 43 | 148 |
| 2022 4 | 123 | 52 | 175 |
| 2022 3 | 96 | 69 | 165 |
| 2022 2 | 101 | 83 | 184 |
| 2022 1 | 90 | 57 | 147 |
| 2021 12 | 105 | 55 | 160 |
| 2021 11 | 91 | 47 | 138 |
| 2021 10 | 105 | 68 | 173 |
| 2021 9 | 75 | 66 | 141 |
| 2021 8 | 86 | 44 | 130 |
| 2021 7 | 80 | 31 | 111 |
| 2021 6 | 87 | 43 | 130 |
| 2021 5 | 112 | 61 | 173 |
| 2021 4 | 251 | 160 | 411 |
| 2021 3 | 126 | 47 | 173 |
| 2021 2 | 77 | 41 | 118 |
| 2021 1 | 68 | 26 | 94 |
| 2020 12 | 73 | 24 | 97 |
| 2020 11 | 60 | 24 | 84 |
| 2020 10 | 0 | 1 | 1 |
| 2020 6 | 1 | 0 | 1 |
Show all
